| Literature DB >> 23287546 |
Moustafa Abdelaal Hegazi1, Tabarek Ahmed Patel, Basem Salama El-Deek.
Abstract
In this study, Entamoeba histolytica had high prevalence and unusual presentation by affecting high proportion of infants under 1 year; severe clinical manifestations, and laboratory findings that were known to be usually encountered in invasive amebiasis as significant leukocytosis for age, neutrophilic leukocytosis for age, and positive C-reactive protein were found among more than 50% of admitted Saudi infants and children with E. histolytica infection in our locality. E. histolytica can be a re-emerging serious infection when it finds favorable environmental conditions and host factors which are mainly attributed to inadequate breastfeeding in this study. This may occur in any other area of the world with the same risk factors, so we must be ready to tackle it with effective and more powerful preventive measures.Entities:
Mesh:
Year: 2013 PMID: 23287546 PMCID: PMC9427352 DOI: 10.1016/j.bjid.2012.08.021
Source DB: PubMed Journal: Braz J Infect Dis ISSN: 1413-8670 Impact factor: 3.257
Comparison of the demographic characteristics between the studied groups.
| Character | RV | Non- | Odds ratio | |||||
|---|---|---|---|---|---|---|---|---|
| Median | 35 months | 11 months | 26 months | |||||
| Range | 1–192 | 2–58 | 3–126 | |||||
| IQ range | 11–68 | 8–30 | 18–84 | |||||
| (Number, %) | 44 | 36.7 | 58 | 51.3 | 103 | 28 | OR 1 = 0.55 (0.31–0.96) | |
| OR 2 = 1.48 (0.93–2.34) | ||||||||
| (Number, %) | 74 | 61.7 | 62 | 54.9 | 218 | 59.4 | OR 1 = 1.32 (0.76–2.31) | |
| OR 2 = 1.1 (0.71–1.72) | ||||||||
| (Number, %) | 115 | 95.8 | 99 | 87.6 | 324 | 88.3 | OR 1 = 3.25 (1.05–10.76) | |
| OR 2 = 3.05 (1.12–8.99) | ||||||||
| (Number, %) | 109 | 90.8 | 101 | 89.2 | 320 | 87.2 | OR 1 = 1.18 (1.09–1.7) | |
| OR 2 = 1.46 (0.7–3.09) | ||||||||
| p3 = 0.53 | ||||||||
p1 group I versus group II; p2 group I versus group III; p3 group II versus group III; OR 1 = group I versus group II; OR 2 = group I versus group III.
Significant difference (p value < 0.05).
Extremely significant difference (p value < 0.001).
Clinical manifestations and laboratory findings of admitted cases of E. histolytica gastroenteritis in the 2 main age groups.
| Age <1 year ( | Age 1–16 years ( | ||||
|---|---|---|---|---|---|
| Number | % | Number | % | ||
| High grade fever ≥39 °C | 28 | 63.6 | 49 | 64.5 | 0.89 |
| Intolerance to oral feeding | 31 | 70.5 | 35 | 46.1 | 0.009 |
| Frequent vomiting | 21 | 47.7 | 28 | 36.8 | 0.24 |
| ≥5 times/day | 34 | 77.3 | 17 | 22.4 | <0.001 |
| Abdominal pain | 5 | 11.4 | 45 | 59.2 | <0.001 |
| Bloody diarrhea | 14 | 31.8 | 23 | 30.3 | 0.85 |
| Dehydration | 27 | 61.4 | 11 | 14.5 | <0.001 |
| Leukocytosis for age | 29 | 65.9 | 39 | 57.4 | 0.15 |
| Neutrophilic leukocytosis for age | 26 | 59.1 | 37 | 50 | 0.27 |
| Positive CRP | 19 | 43.2 | 41 | 55.4 | 0.25 |
Highly significant difference when p value < 0.05 and > 0.001.
Extremely significant difference (p value < 0.001).
Comparison of the risk factors for gastroenteritis between the studied groups.
| Variable | RV | Non- | Odds ratio | |||||
|---|---|---|---|---|---|---|---|---|
| Secondary school and less (Number, %) | OR 1 = 1.01 (0.58–1.79) | |||||||
| 45 | 37.5 | 42 | 37.2 | 145 | 39.5 | OR 2 = 0.92 (0.59–1.43) | ||
| Secondary school and less (Number, %) | OR 1 = 1.64 (0.95–2.85) | |||||||
| 70 | 58.33 | 52 | 46.01 | 202 | 55.04 | OR 2 = 0.87 (0.56–1.35) | ||
| (Number, %) | 112 | 93.3 | 105 | 92.9 | 334 | 91 | OR 1 = 1.07 (0.35–3.26) | |
| OR 2 = 1.38 (0.59–3.35) | ||||||||
| (Number, %) | 10 | 8.3 | 13 | 11.5 | 67 | 8.1 | OR 1 = 0.70 (0.27–1.79) | |
| OR 2 = 0.41 (0.19–15.7) | ||||||||
| (Number, %) | 103 | 85.3 | 46 | 40.7 | 151 | 41.1 | OR 1 = 8.82 (4 .48–15.7) | |
| OR 2 = 8.67 (4 .84–15.7) | ||||||||
| (Number, %) | OR 1 = 2.14 (0.75–16.75) | |||||||
| 120 | 100 | 111 | 98.2 | 361 | 98.4 | OR 2 = 0.94 (0.23–3.16) | ||
| (Number, %) | 10 | 8.3 | 9 | 7.9 | 31 | 8.4 | OR 1 = 1.05 (0.38–2.95) | |
| OR 2 = 0.99 (0.98–2.18) | ||||||||
| (Number, %) | 13 | 10.8 | 11 | 9.7 | 29 | 7.9 | OR 1 = 1.13 (0.45–2.84) | |
| OR 2 = 1.42 (0.67–2.95) | ||||||||
p1 group I versus group II; p2 group I versus group III; p3 group II versus group III; OR 1 = group I versus group II;OR 2 = group I versus group III.
Extremely significant difference (p value < 0.001).
Comparison of the laboratory findings between the studied groups.
| Variable | RV | Non- | Odds ratio | |||||
|---|---|---|---|---|---|---|---|---|
| (Number, %) | 68 | 56.7 | 7 | 6.2 | 32 | 8.7 | OR 1 = 19.8 (8.05–50.9) | |
| OR 2 = 13.69 (7.69–23.64) | ||||||||
| 63/68 | 5/7 | 14/32 | OR 1 = 5.04 (0.52–44.8) | |||||
| OR 2 = 16.2 (4 .46–60.92) | ||||||||
| (Number, %) | 60 | 50 | 13 | 11.5 | 73 | 20 | OR 1 = 7.69 (3.73–16.12) | |
| OR 2 = 4.03 (2.53-6.41) | ||||||||
p1 group I versus group II; p2 group I versus group III; p3 group II versus group III; OR 1 = group I versus group II; OR 2 = group I versus group III.
Significant difference (p value < 0.05).